{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["In silico", "Inhibitors", "Metabolites", "Neutralization", "Snake venom"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "31953201", "DateCompleted": {"Year": "2020", "Month": "11", "Day": "09"}, "DateRevised": {"Year": "2020", "Month": "11", "Day": "09"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "01", "Day": "15"}], "Language": ["eng"], "ELocationID": ["10.1016/j.jep.2020.112575", "S0378-8741(19)31481-3"], "Journal": {"ISSN": "1872-7573", "JournalIssue": {"Volume": "252", "PubDate": {"Year": "2020", "Month": "Apr", "Day": "24"}}, "Title": "Journal of ethnopharmacology", "ISOAbbreviation": "J Ethnopharmacol"}, "ArticleTitle": "Metabolites from the citrus extracts inhibit the activity of selected proteins in Indian Cobra (Naja naja) venom.", "Pagination": {"StartPage": "112575", "MedlinePgn": "112575"}, "Abstract": {"AbstractText": ["Snakebite is a severe problem in many parts of the world, specifically in tropical and subtropical regions. A range of medicinal plant extracts are administered for treating snake bite. Of the many common plants, extracts of Citrus species have been documented to be used for treating snake bite and have been shown to decrease the snake venom toxicity.", "The aim of the current work is to evaluate the utility of citrus peel extracts (Citrus aurantium L. and Citrus reticulate Blanco) in the management of Indian cobra envenomation.", "Peels of citrus species were evaluated for their phospholipase A<sub>2</sub>, protease and haemolytic inhibition properties. The phytochemicals present in the extract were inferred using GC-MS. In-vivo studies, using mice model, were done to confirm the inhibitory effect of the extracts. Molecular docking was used to understand the possible binding modes of selected phytochemicals to snake venom phospholipase.", "Citrus peel extracts are rich in polyphenols, flavonoids and tannins. The methanolic extract of Citrus aurantium L. and Citrus reticulate Blanco inhibits phospholipase (75%), protease (71%) and hemolysis (80%) activity of the venom. GC-MS analyses indicate the presence of \u03b2-sitosterol, n-hexadecanoic acid, eicosanoic acid, and flavone in both the extracts. In addition, C. reticulate extract contains \u03b1-tocopherol and squalene. Molecular docking revealed that \u03b1-tocopherol, spiro [androst-5-ene-17,1'-cyclobutan]-2'-one,3-hydroxy-(3\u03b2,17\u03b2)- and \u03b2-sitosterol acetate bind with moderate affinity to the catalytic site of phospholipase A2.", "The present study provides new molecular insight and scientific evidence on the utility of the methanolic extracts of citrus peels to neutralize the venom toxins of Naja naja."], "CopyrightInformation": "Copyright \u00a9 2020 Elsevier B.V. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Biosciences and Technology (SBST), Vellore Institute of Technology, Vellore, 632014, India. Electronic address: r.srimathi@vit.ac.in."}], "LastName": "R", "ForeName": "Srimathi", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Biosciences and Technology (SBST), Vellore Institute of Technology, Vellore, 632014, India. Electronic address: gjayaraman@vit.ac.in."}], "LastName": "Gurunathan", "ForeName": "Jayaraman", "Initials": "J"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Ireland", "MedlineTA": "J Ethnopharmacol", "NlmUniqueID": "7903310", "ISSNLinking": "0378-8741"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Elapid Venoms"}, {"RegistryNumber": "0", "NameOfSubstance": "Phospholipase A2 Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Phytochemicals"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "Protease Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Reptilian Proteins"}, {"RegistryNumber": "EC 3.1.1.4", "NameOfSubstance": "Phospholipases A2"}, {"RegistryNumber": "EC 3.4.-", "NameOfSubstance": "Peptide Hydrolases"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Citrus"}, {"QualifierName": ["enzymology"], "DescriptorName": "Elapid Venoms"}, {"QualifierName": ["drug effects"], "DescriptorName": "Hemolysis"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Naja naja"}, {"QualifierName": ["metabolism"], "DescriptorName": "Peptide Hydrolases"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Phospholipase A2 Inhibitors"}, {"QualifierName": ["metabolism"], "DescriptorName": "Phospholipases A2"}, {"QualifierName": ["analysis", "pharmacology"], "DescriptorName": "Phytochemicals"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Protease Inhibitors"}, {"QualifierName": ["antagonists & inhibitors", "metabolism"], "DescriptorName": "Reptilian Proteins"}], "CoiStatement": "Declaration of competing interest The authors declare that there are no conflicts of interest."}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2019", "Month": "4", "Day": "12"}, {"Year": "2019", "Month": "11", "Day": "18"}, {"Year": "2020", "Month": "1", "Day": "13"}, {"Year": "2020", "Month": "1", "Day": "19", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "11", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "1", "Day": "19", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["31953201", "10.1016/j.jep.2020.112575", "S0378-8741(19)31481-3"]}}]}